OpenAI CEO Sam Altman is under fire for suggesting that artificial intelligence will upend societal norms after President ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
OpenAI CEO Sam Altman is battling rumors surrounding superintelligence and AGI (artificial general intelligence). Is ChatGPT ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...